Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC. - Wikidata - wikimedia - TriplyDB

Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC.

Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC.

http://www.wikidata.org/entity/Q39352144

about

The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cells.HSP90 Inhibitors, Geldanamycin and Radicicol, Enhance Fisetin-Induced Cytotoxicity via Induction of Apoptosis in Human Colonic Cancer Cells.HSP90 Inhibitor SNX5422/2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell Carcinoma.Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action.Effects of fusaric acid treatment on HEp2 and docetaxel-resistant HEp2 laryngeal squamous cell carcinoma.DTNQ-Pro, a Mimetic Dipeptide, Sensitizes Human Colon Cancer Cells to 5-Fluorouracil Treatment.Targeting Hodgkin and Reed-Sternberg Cells with an Inhibitor of Heat-Shock Protein 90: Molecular Pathways of Response and Potential Mechanisms of Resistance.Analysis of HSP90 Expression Is Valuable in the Differential Diagnosis of Ocular Surface Squamous Lesions.

P2860

Q36546425-39068A5E-28F9-4CA7-9FD7-2774F5D80C82 Q36956034-BAD63050-ACC0-4785-BB34-23777E54A030 Q37060950-4B298CF1-4BD7-4D6F-B645-D9BC4A5D983B Q37724010-20911D66-A5D0-42FC-9562-C5A60F042C34 Q39093935-C219BAA6-E452-4CB8-9478-42AF37D99EE9 Q40715421-EC0F88B2-329B-4E90-BA6C-16F7CB21195F Q52658034-60225639-A974-4F05-8266-713AD3D68AEA Q54117138-C690481D-0262-4420-BBFE-6BDA3C14691C

P2860

Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC.

http://www.wikidata.org/entity/Q39352144

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Pharmacological inhibition of ...... egy in the treatment of HNSCC.

@en

Pharmacological inhibition of ...... egy in the treatment of HNSCC.

@nl

type

label

Pharmacological inhibition of ...... egy in the treatment of HNSCC.

@en

Pharmacological inhibition of ...... egy in the treatment of HNSCC.

@nl

prefLabel

Pharmacological inhibition of ...... egy in the treatment of HNSCC.

@en

Pharmacological inhibition of ...... egy in the treatment of HNSCC.

@nl

P1433

Q39352144-54938836-5DA8-4377-827A-62FCC6881736

P1476

Q39352144-D3FE6C0B-8551-4E7C-A7E6-EB4F0B551982

P2093

Q39352144-4CC6F4AE-0922-41D3-89A6-FCDCC6896B0E

Q39352144-5F7E55B0-7227-4BAE-8FFF-922B59B63086

Q39352144-6D421F52-B685-465E-9090-9F6CE24262A7

Q39352144-A7CBF94F-17A5-467C-B8A6-8BB92B1EAD3A

Q39352144-B15171C8-1D44-43ED-A2EB-AF8D983A90D6

P2860

Q39352144-056CE74B-9CC3-4A4B-84DF-5E05164AB93B

Q39352144-0A6E294C-B247-40DC-AF66-71A5E7CD9F16

Q39352144-104AC11C-7D15-424E-91FC-875F5A44C04E

Q39352144-10CDA7AF-16BB-481C-BD60-8C94717CD7E3

Q39352144-1B4EC502-78A5-4BBE-8D76-1E158E1BB22C

Q39352144-26324EAA-3C17-4C45-B9E4-9A0B116776D4

Q39352144-48DB870E-1E7B-4717-A71A-BBCBA4EA1C00

Q39352144-4C6324A0-6F19-4434-ACB5-B700AC1D9749

Q39352144-5D6BA926-49C6-4598-A4A5-C2DE1C18D95E

Q39352144-60081C89-B1BA-4DCF-BE2E-2E2E51EA1E0C

P304

Q39352144-A336F588-95DD-40E5-B423-1C264739863F

P31

Q39352144-CCFC8BB7-F85E-4AAD-A1CA-DCA3449BF220

P356

Q39352144-1555254A-D786-4C9C-8472-C2EC23941CBA

P433

Q39352144-150BD1C0-5EBA-4497-AEBC-D17DFB91E540

P478

Q39352144-690E89E0-2421-4457-B9BF-8F555880B4B9

P50

Q39352144-0CF4E41A-6B47-4852-A66A-25DAF3129B6F

Q39352144-1B101013-AC93-4A20-8F4B-E5B6CB4288CE

Q39352144-9271B1CE-2B4B-4BD7-850C-A5270657EC4E

Q39352144-9798C285-DF3E-4A5E-B0A1-E884F6DE8E91

P577

Q39352144-38233AC5-5D19-458E-8279-1D4886FAF6D5

P5875

Q39352144-291E1B29-434F-41FF-ABB9-969A556EE650

P698

Q39352144-601ECA1C-A649-4EA9-821E-346875A6DF05

P921

Q39352144-04430C54-CD2B-4BB0-BBC4-57050795292D

P356

P1433

Journal of Cellular Physiology

P1476

Pharmacological inhibition of ...... egy in the treatment of HNSCC.

@en

P2093

Alberto Abbruzzese

http://www.w3.org/2001/XMLSchema#string

Anna Grimaldi

http://www.w3.org/2001/XMLSchema#string

Filippo Ricciardiello

http://www.w3.org/2001/XMLSchema#string

Gaia Giuberti

http://www.w3.org/2001/XMLSchema#string

Pierosandro Tagliaferri

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2008

Hsp90 inhibitors: small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation

Mechanisms of Taxol resistance related to microtubules.

The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review.

Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway.

The taxanes: an update.

Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues.

Hsp90: chaperoning signal transduction.

Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer.

Emerging strategies for the early detection and prevention of head and neck squamous cell cancer

P304

130-141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCP.24112

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

228

http://www.w3.org/2001/XMLSchema#string

P50

Gabriella Misso

Michele Caraglia

Antonio Giordano

Angela Lombardi

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224918596

http://www.w3.org/2001/XMLSchema#string

P698

22566192

http://www.w3.org/2001/XMLSchema#string

P921